NUVB Nuvation Bio Inc. Class A Common Stock
$6,73
Kurs · Aug 24, 2026
Fundamentaldaten per Aug 6, 2026
52W-Spanne
$3–$10
56% of range
Analystenbewertung
BUY
16 analysts
Kursziel
$13
+95% upside
P/E (TTM)
-11.5
ROE
-60.3%
Nettogewinnmarge
-325.3%
NUVB Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$6.73
Marktkapitalisierung
$2.33B
P/E (TTM)
-11.5
EPS (TTM)
$-0.60
Umsatz (TTM)
$63M
Dividendenrendite
—
ROE
-60.3%
Verschuldungsgrad
0.0
52W-Spanne
$3 – $10
NUVB Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Configure
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz & Nettoergebnis
$63M
2023-12-31
→
2025-12-31
EPS
$-0.60
2021-12-31
→
2025-12-31
Freier Cashflow
—
Margen
-325.3%
2024-12-31
→
2024-12-31
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
Kennzahl
5-Jahres-Trend
NUVB
Peer-Median
P/E (TTM)
-11.5
19.1
P/S (TTM) (K/V (TTM))
37.1
14.2
P/B (K/B)
7.6
3.6
EV / EBITDA
-8.5
—
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
Kennzahl
5-Jahres-Trend
NUVB
Peer-Median
Operating Margin (Betriebsgewinnmarge)
-338.7%
—
Net Profit Margin (Nettogewinnmarge)
-325.3%
-4.3%
ROA
-36.0%
-2.9%
ROE
-60.3%
-6.8%
ROIC
-68.4%
—
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
Kennzahl
5-Jahres-Trend
NUVB
Peer-Median
Debt / Equity (Fremdkapital / Eigenkapital)
0.0
—
Current Ratio (Liquiditätsgrad)
7.0
4.7
Quick Ratio
6.4
—
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
Kennzahl
5-Jahres-Trend
NUVB
Peer-Median
Revenue YoY (Umsatz YoY)
699.0%
—
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
Kennzahl
5-Jahres-Trend
NUVB
Peer-Median
NUVB Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
KAUF
16 Analysten
- Starker Kauf 4 25,0%
- Kauf 10 62,5%
- Halten 2 12,5%
- Verkauf 0 0,0%
- Starker Verkauf 0 0,0%
12-Monats-Kursziel
10 Analysten · 2026-08-20
Median
$12.50
← Unter allen Zielen
$6.73
Tief
$7.00
Hoch
$21.00
Median-Ziel
$12.50
+85,7%
Mittelwert-Ziel
$13.10
+94,7%
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
0.01%
| Zeitraum | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|
| 30. Juni 2026 | $-0.15 | $-0.19 | 0.04% |
| 31. März 2026 | $0.01 | $0.01 | 0.00% |
| 31. Dezember 2025 | $-0.11 | $-0.09 | -0.02% |
| 30. September 2025 | $-0.16 | $-0.17 | 0.01% |
| 30. Juni 2025 | $-0.17 | $-0.17 | 0.00% |
| 31. März 2025 | $-0.16 | $-0.16 | 0.00% |
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| NUVB | $3.03B | -14.9 | 699.0% | -325.3% | -60.3% | — |
| TRVI | $1.61B | -39.1 | — | — | -22.4% | — |
| NKTR | $862M | -4.3 | -43.9% | -297.1% | -500.1% | — |
| PBH | $3.33B | 15.2 | -4.3% | 17.5% | 10.2% | 54.7% |
| AMRX | — | 57.3 | 8.1% | 2.4% | -80.0% | 36.9% |
| OCUL | $2.62B | -8.5 | -18.5% | -511.9% | -55.4% | — |
| RAPP | $1.45B | -10.6 | — | — | -29.8% | — |
| HRMY | $2.16B | 13.8 | 21.5% | 18.3% | 19.3% | 77.2% |
| TRLV | — | — | -0.45% | -10.3% | -10.4% | 60.2% |
| KARD | — | — | — | — | — | — |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung 16
| Kennzahl | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue | $63M | $8M | $0 | |
| Cost of Revenue | · | $7M | $0 | |
| Gross Profit | · | $795.0K | $0 | |
| R&D Expense | $115M | $99M | $71M | |
| SG&A Expense | $152M | $69M | $29M | |
| Operating Expenses | $276M | $600M | $100M | |
| Operating Income | $-213M | $-593M | $-100M | |
| Other Non-op | $2M | $-109.0K | $24M | |
| Pretax Income | $-205M | $-568M | $-76M | |
| Income Tax | $0 | $0 | $0 | |
| Net Income | $-205M | $-568M | $-76M | |
| EPS (Basic) | $-0.60 | $-2.11 | $-0.35 | |
| EPS (Diluted) | $-0.60 | $-2.11 | $-0.35 | |
| Shares (Basic) | 341,541 | 268,772 | 218,880 | |
| Shares (Diluted) | 341,541 | 268,772 | 218,880 | |
| EBITDA | $-213M | $-593M | · |
Bilanz 25
| Kennzahl | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Cash & Equivalents | $164M | $36M | $43M | |
| Short-term Investments | $365M | $467M | $569M | |
| Inventory | $11M | $0 | · | |
| Prepaid Expense | $12M | $7M | $2M | |
| Current Assets | $572M | $526M | $616M | |
| PP&E (Net) | $564.0K | $586.0K | $717.0K | |
| PP&E (Gross) | $2M | $1M | $1M | |
| Accum. Depreciation | $1M | $874.0K | $666.0K | |
| Intangibles | $11M | $5M | $0 | |
| Other Non-current Assets | $8M | $7M | $587.0K | |
| Total Assets | $595M | $541M | $621M | |
| Accounts Payable | $9M | $6M | $2M | |
| Accrued Liabilities | $45M | $33M | $10M | |
| Short-term Debt | $6M | $6M | $0 | |
| Current Liabilities | $82M | $58M | $14M | |
| Capital Leases | $3M | $969.0K | $2M | |
| Total Liabilities | $289M | $77M | $16M | |
| Long-term Debt | $47M | · | · | |
| Total Debt | $6M | $6M | · | |
| Common Stock | $1.42B | $1.37B | $948M | |
| Retained Earnings | $-1.12B | $-911M | $-343M | |
| AOCI | $-187.0K | $573.0K | $181.0K | |
| Stockholders' Equity | $306M | $464M | $605M | |
| Liabilities + Equity | $595M | $541M | $621M | |
| Shares Outstanding | 346,503,675 | 337,837,872 | 219,046,219 |
Cashflow 6
| Kennzahl | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| D&A | $2M | $683.0K | $222.0K | |
| Stock-based Comp | $36M | $32M | $20M | |
| Operating Cash Flow | $-173M | $-130M | $-68M | |
| Investing Cash Flow | $100M | $123M | $9M | |
| Financing Cash Flow | $203M | $331.0K | $628.0K | |
| Net Change in Cash | $128M | $-7M | $-58M |
Rentabilität 8
| Kennzahl | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Gross Margin | · | 10.1% | · | |
| Operating Margin | -338.7% | -7527.3% | · | |
| Net Margin | -325.3% | -7213.8% | · | |
| Pretax Margin | -325.3% | -7213.8% | · | |
| EBITDA Margin | -338.7% | -7527.3% | · | |
| ROA | -36.0% | -97.7% | · | |
| ROE | -60.3% | -117.5% | · | |
| ROIC | -68.4% | -126.1% | · |
Liquidität & Solvenz 3
| Kennzahl | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Current Ratio | 7.0 | 9.0 | · | |
| Quick Ratio | 6.4 | 8.6 | · | |
| Debt / Equity | 0.0 | 0.0 | · |
Effizienz 1
| Kennzahl | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.0 | · |
Wachstumsraten 1
| Kennzahl | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue YoY | 699.0% | · | · |
Bewertung (TTM) 12
| Kennzahl | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue TTM | $63M | $8M | $0 | |
| Net Income TTM | $-205M | $-568M | $-76M | |
| Market Cap | $3.03B | $899M | · | |
| Enterprise Value | $2.50B | $402M | · | |
| P/E | -14.9 | -1.3 | -4.3 | |
| P/S | 48.1 | 114.1 | · | |
| P/B | 9.9 | 1.9 | · | |
| P / Tangible Book | 10.3 | 2.0 | 0.5 | |
| P / Cash Flow | -17.5 | -6.9 | · | |
| EV / EBITDA | -11.8 | -0.7 | · | |
| EV / Revenue | 39.8 | 51.1 | · | |
| Earnings Yield | -6.7% | -79.3% | -23.2% |
Gewinn- und Verlustrechnung 17
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $32M | $83M | $42M | $13M | $5M | $3M | $6M | $727.0K | $1M | $0 | $0 | $0 | $0 | |
| Cost of Revenue | · | · | · | $3M | $3M | $2M | · | $2M | $1M | $0 | · | · | · | |
| Gross Profit | · | · | · | $10M | $2M | $990.0K | · | $-788.0K | $88.0K | $0 | $0 | $0 | $0 | |
| R&D Expense | $31M | $35M | $34M | $29M | $27M | $25M | $29M | $28M | $29M | $13M | $15M | $19M | $19M | |
| SG&A Expense | $43M | $38M | $40M | $37M | $38M | $35M | $26M | $20M | $16M | $7M | $5M | $8M | $8M | |
| Operating Expenses | $83M | $79M | $84M | $66M | $68M | $62M | $63M | $47M | $470M | $20M | $21M | $26M | $26M | |
| Operating Income | $-51M | $4M | $-34M | $-56M | $-64M | $-59M | $-54M | $-48M | $-470M | $-20M | $-21M | $-26M | $-26M | |
| Interest Expense | · | · | · | $5M | · | · | · | · | $132.0K | · | · | · | $0 | |
| Other Non-op | $-12M | $2M | $-9M | $642.0K | $5M | $6M | $-20M | $7M | $8M | $5M | $7M | $7M | $5M | |
| Pretax Income | $-63M | $5M | $-37M | $-56M | $-59M | $-53M | $-49M | $-41M | $-462M | $-15M | $-14M | $-20M | $-21M | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-63M | $5M | $-37M | $-56M | $-59M | $-53M | $-49M | $-41M | $-462M | $-15M | $-14M | $-20M | $-21M | |
| EPS (Basic) | $-0.18 | $0.02 | $-0.11 | $-0.16 | $-0.17 | $-0.16 | $0.00 | $-0.15 | $-1.89 | $-0.07 | $-0.07 | $-0.09 | $-0.09 | |
| EPS (Diluted) | $-0.18 | $0.01 | $-0.11 | $-0.16 | $-0.17 | $-0.16 | $0.00 | $-0.15 | $-1.89 | $-0.07 | $-0.07 | $-0.09 | $-0.09 | |
| Shares (Basic) | 348,770 | 347,332 | -680,210 | 342,393 | 340,746 | 338,612 | -468,579 | 273,565 | 244,738 | 219,048 | -437,644 | 218,935 | 218,848 | |
| Shares (Diluted) | 348,770 | 377,521 | -680,210 | 342,393 | 340,746 | 338,612 | -468,579 | 273,565 | 244,738 | 219,048 | -437,644 | 218,935 | 218,848 | |
| EBITDA | $-51M | $4M | · | $-56M | $-64M | $-59M | · | $-48M | $-470M | $-20M | · | $-26M | $-26M |
Bilanz 25
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $259M | $125M | $164M | $99M | $248M | $48M | $36M | $30M | $34M | $35M | $43M | $24M | $50M | |
| Short-term Investments | $402M | $408M | $365M | $450M | $360M | $414M | $467M | $519M | $543M | $562M | $569M | $595M | $581M | |
| Inventory | $20M | $16M | $11M | $6M | $552.0K | $14.0K | $0 | · | · | · | · | · | · | |
| Prepaid Expense | $14M | $16M | $12M | $9M | $8M | $8M | $7M | $12M | $6M | $7M | $2M | $3M | $4M | |
| Current Assets | $726M | $592M | $572M | $578M | $623M | $476M | $526M | $565M | $587M | $608M | $616M | $625M | $637M | |
| PP&E (Net) | $715.0K | $535.0K | $564.0K | $560.0K | $615.0K | $562.0K | $586.0K | $719.0K | $751.0K | $686.0K | $717.0K | $764.0K | $804.0K | |
| PP&E (Gross) | · | · | $2M | · | · | · | $1M | · | · | · | $1M | · | · | |
| Accum. Depreciation | $1M | $1M | $1M | $1M | $1M | $971.0K | $874.0K | $839.0K | $782.0K | · | $666.0K | · | · | |
| Intangibles | $10M | $11M | $11M | $12M | $12M | $4M | $5M | $3M | $3M | · | $0 | · | · | |
| Other Non-current Assets | $4M | $4M | $8M | $7M | $7M | $7M | $7M | $480.0K | $1M | $1M | $587.0K | $587.0K | · | |
| Total Assets | $745M | $610M | $595M | $602M | $647M | $492M | $541M | $572M | $595M | $613M | $621M | $631M | $641M | |
| Accounts Payable | $12M | $22M | $9M | $15M | $22M | $11M | $6M | $12M | $5M | $2M | $2M | $2M | $3M | |
| Accrued Liabilities | $45M | $33M | $45M | $33M | $24M | $24M | $33M | $24M | $20M | $11M | $10M | $12M | $10M | |
| Short-term Debt | $6M | $6M | $6M | $6M | $6M | $6M | $6M | $8M | $12M | · | $0 | · | · | |
| Current Liabilities | $87M | $80M | $82M | $68M | $66M | $53M | $58M | $59M | $51M | $16M | $14M | $16M | $13M | |
| Capital Leases | $2M | $2M | $3M | $3M | $3M | $4M | $969.0K | $985.0K | $972.0K | $2M | $2M | $3M | $2M | |
| Total Liabilities | $491M | $291M | $289M | $276M | $274M | $73M | $77M | $69M | $63M | $19M | $16M | $19M | $17M | |
| Long-term Debt | $243M | $47M | $47M | $47M | $47M | · | · | · | · | · | · | · | · | |
| Total Debt | $6M | $6M | · | $6M | $6M | $6M | · | $8M | $12M | · | · | · | · | |
| Common Stock | $1.43B | $1.43B | $1.42B | $1.40B | $1.40B | $1.38B | $1.37B | $1.36B | $1.08B | $953M | $948M | $944M | $938M | |
| Retained Earnings | $-1.17B | $-1.11B | $-1.12B | $-1.08B | $-1.02B | $-964M | $-911M | $-861M | $-820M | $-358M | $-343M | $-329M | $-309M | |
| AOCI | $-3M | $-2M | $-187.0K | $-139.0K | $-327.0K | $545.0K | $573.0K | $1M | $-1M | $-1M | $181.0K | $-3M | $-4M | |
| Stockholders' Equity | $254M | $320M | $306M | $326M | $373M | $419M | $464M | $503M | $257M | $594M | $605M | $612M | $625M | |
| Liabilities + Equity | $745M | $610M | $595M | $602M | $647M | $492M | $541M | $572M | $595M | $613M | $621M | $631M | $641M | |
| Shares Outstanding | 346,503,675 | 346,503,675 | 337,837,872 | 337,837,872 | 337,837,872 | 337,837,872 | 337,837,872 | 336,248,642 | 248,624,729 | 219,083,219 | 219,046,219 | 218,944,053 | 218,899,462 |
Cashflow 6
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $536.0K | $536.0K | $539.0K | $534.0K | $356.0K | $310.0K | $219.0K | $162.0K | $244.0K | $58.0K | $55.0K | $55.0K | $56.0K | |
| Stock-based Comp | $10M | $9M | $8M | $8M | $12M | $8M | $10M | $7M | $10M | $5M | $4M | $5M | $6M | |
| Operating Cash Flow | $-43M | $5M | $-30M | $-53M | $-48M | $-43M | $-46M | $-31M | $-37M | $-16M | $-15M | $-16M | $-17M | |
| Investing Cash Flow | $6M | $-44M | $87M | $-97M | $55M | $54M | $52M | $29M | $34M | $8M | $33M | $-10M | $37M | |
| Financing Cash Flow | $171M | $44.0K | $8M | $501.0K | $193M | $548.0K | $-900.0K | $-2M | $3M | $21.0K | $120.0K | $77.0K | $133.0K | |
| Net Change in Cash | $133M | $-39M | $65M | $-149M | $200M | $12M | $6M | $-4M | $-225.0K | $-8M | $18M | $-26M | $20M |
Rentabilität 8
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | · | 74.5% | 46.7% | 32.1% | · | -108.4% | 6.1% | · | · | · | · | |
| Operating Margin | -161.1% | 4.7% | · | -430.1% | -1315.7% | -1913.2% | · | -6616.4% | -32779.4% | · | · | · | · | |
| Net Margin | -198.3% | 6.5% | · | -425.2% | -1220.9% | -1726.2% | · | -5668.5% | -32229.4% | · | · | · | · | |
| Pretax Margin | -198.3% | 6.5% | · | -425.2% | -1220.9% | -1726.2% | · | -5668.5% | -32229.4% | · | · | · | · | |
| EBITDA Margin | -161.1% | 4.7% | · | -430.1% | -1315.7% | -1913.2% | · | -6616.4% | -32779.4% | · | · | · | · | |
| ROA | -9.0% | 0.98% | · | -9.5% | -9.5% | -9.6% | · | -6.9% | -74.8% | -2.3% | · | -3.0% | -3.0% | |
| ROE | -20.1% | 1.5% | · | -13.5% | -18.7% | -10.5% | · | -7.4% | -104.9% | -2.4% | · | -3.1% | -3.1% | |
| ROIC | -19.7% | 1.2% | · | -17.0% | -16.8% | -13.9% | · | -9.4% | -175.0% | -3.4% | · | -4.3% | -4.2% |
Liquidität & Solvenz 4
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 8.4 | 7.4 | · | 8.5 | 9.4 | 9.0 | · | 9.6 | 11.5 | 38.6 | · | 38.7 | 47.5 | |
| Quick Ratio | 7.6 | 6.7 | · | 8.1 | 9.2 | 8.7 | · | 9.3 | 11.3 | 37.9 | · | 38.4 | 47.0 | |
| Debt / Equity | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | · | · | · | · | |
| Interest Coverage | · | · | · | -11.0 | · | · | · | · | -3563.5 | · | · | · | · |
Effizienz 2
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.2 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | · | · | · | · | |
| Inventory Turnover | · | · | · | 1.2 | 9.3 | 299.1 | · | · | · | · | · | · | · |
Bewertung (TTM) 12
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $133M | $104M | · | $22M | $10M | $5M | · | $2M | $1M | · | · | · | · | |
| Net Income TTM | $-172M | $-163M | · | $-209M | $-616M | $-572M | · | $-538M | $-518M | $-77M | · | $-89M | $-104M | |
| Market Cap | $1.97B | $1.49B | · | $1.25B | $659M | $595M | · | $770M | $726M | $797M | · | $293M | $394M | |
| Enterprise Value | $1.31B | $959M | · | $707M | $57M | $139M | · | $229M | $160M | · | · | · | · | |
| P/E | -11.4 | -8.9 | · | -5.8 | -0.8 | -0.8 | · | -1.0 | -1.4 | -10.4 | · | -3.4 | -3.8 | |
| P/S | 14.8 | 14.3 | · | 57.4 | 65.4 | 113.3 | · | 356.2 | 505.9 | · | · | · | · | |
| P/B | 7.8 | 4.7 | · | 3.8 | 1.8 | 1.4 | · | 1.5 | 2.8 | 1.3 | · | 0.5 | 0.6 | |
| P / Tangible Book | 8.1 | 4.8 | · | 4.0 | 1.8 | 1.4 | · | 1.5 | 2.9 | 1.3 | · | 0.5 | 0.6 | |
| P / Cash Flow | · | 293.3 | · | · | · | -13.9 | · | · | · | -50.8 | · | · | · | |
| EV / EBITDA | -25.7 | 247.0 | · | -12.5 | -0.9 | -2.3 | · | -4.8 | -0.3 | · | · | · | · | |
| EV / Revenue | 9.9 | 9.2 | · | 32.5 | 5.6 | 26.4 | · | 106.1 | 111.8 | · | · | · | · | |
| Earnings Yield | -8.8% | -11.2% | · | -17.3% | -121.5% | -129.0% | · | -96.1% | -73.3% | -9.6% | · | -29.8% | -26.1% |
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
Gewinn- und Verlustrechnung
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Umsatz | $63M | $8M | $0 | — | — |
| Bruttogewinnmarge % | — | 10.1% | — | — | — |
| Betriebsgewinnmarge % | -338.7% | -7527.3% | — | — | — |
| Nettoergebnis | $-205M | $-568M | $-76M | $-104M | $-87M |
| Verwässerte EPS | $-0.60 | $-2.11 | $-0.35 | $-0.48 | $-0.44 |
Bilanz
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Fremdkapital / Eigenkapital | 0.0 | 0.0 | — | — | — |
| Liquiditätsgrad | 7.0 | 9.0 | — | 50.7 | 45.6 |
| Quick Ratio | 6.4 | 8.6 | — | 50.2 | 45.2 |
Neueste Nachrichten Aktuelle Schlagzeilen über dieses Unternehmen
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
📊
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das ➕ neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Institutionelle Eigentümer (13F) 258 Einreicher · $945.6M gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 38 (-10 vs. Vorquartal) | 24 (-9 vs. Vorquartal) | 105 (+23 vs. Vorquartal) | 53 (-12 vs. Vorquartal) | +11.9M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| FMR LLC | $164.210.680 | 28.910.331 | 17,37% | Aktien |
| Decheng Capital LLC | $147.421.214 | 25.954.439 | 15,59% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $67.702.840 | 11.919.514 | 7,16% | Aktien |
| Omega Fund Management, LLC | $45.900.586 | 8.081.089 | 4,85% | Aktien |
| Laurion Capital Management LP | $44.417.674 | 7.820.013 | 4,70% | Aktien |
| STATE STREET CORP | $41.866.110 | 7.370.794 | 4,43% | Aktien |
| UBS Group AG | $36.208.324 | 6.374.705 | 3,83% | Kaufoption |
| GEODE CAPITAL MANAGEMENT, LLC | $30.251.706 | 5.324.691 | 3,20% | Aktien |
| AMERICAN CENTURY COMPANIES INC | $25.557.979 | 4.499.643 | 2,70% | Aktien |
| BANK OF AMERICA CORP /DE/ | $19.073.895 | 3.358.080 | 2,02% | Aktien |
| TANG CAPITAL MANAGEMENT LLC | $18.741.484 | 3.299.557 | 1,98% | Aktien |
| Redmile Group, LLC | $17.216.131 | 3.031.009 | 1,82% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $15.271.623 | 2.688.666 | 1,62% | Aktien |
| ALGERT GLOBAL LLC | $12.935.393 | 2.277.358 | 1,37% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $11.694.382 | 2.058.870 | 1,24% | Aktien |
| DIMENSIONAL FUND ADVISORS LP | $11.631.595 | 2.047.816 | 1,23% | Aktien |
| ARMISTICE CAPITAL, LLC | $11.360.000 | 2.000.000 | 1,20% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $10.090.827 | 1.776.554 | 1,07% | Aktien |
| Connor, Clark & Lunn Investment Management Ltd. | $9.966.952 | 1.754.745 | 1,05% | Aktien |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $9.211.176 | 1.621.686 | 0,97% | Aktien |
| Knoll Capital Management, LLC | $9.079.996 | 1.598.591 | 0,96% | Aktien |
| GOLDMAN SACHS GROUP INC | $7.988.102 | 1.406.356 | 0,84% | Aktien |
| RENAISSANCE TECHNOLOGIES LLC | $7.645.252 | 1.345.995 | 0,81% | Aktien |
| FIRST TRUST ADVISORS LP | $7.397.274 | 1.302.337 | 0,78% | Aktien |
| ABRAMS CAPITAL MANAGEMENT, L.P. | $7.216.463 | 1.270.504 | 0,76% | Aktien |
| CITADEL ADVISORS LLC | $7.121.698 | 1.253.820 | 0,75% | Aktien |
| TWO SIGMA INVESTMENTS, LP | $7.090.963 | 1.248.409 | 0,75% | Aktien |
| NewEdge Advisors, LLC | $6.996.243 | 1.231.733 | 0,74% | Aktien |
| SILVERCREST ASSET MANAGEMENT GROUP LLC | $5.802.268 | 1.021.526 | 0,61% | Aktien |
| Woodline Partners LP | $5.541.022 | 975.532 | 0,59% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $5.195.945 | 914.779 | 0,55% | Aktien |
| BlackRock, Inc. | $3.984.071 | 701.421 | 0,42% | Aktien |
| ESSEX INVESTMENT MANAGEMENT CO LLC | $3.811.513 | 671.041 | 0,40% | Aktien |
| Beacon Pointe Advisors, LLC | $3.591.186 | 632.251 | 0,38% | Aktien |
| TWO SIGMA ADVISERS, LP | $3.522.176 | 393.100 | 0,37% | Aktien |
| EDBI Pte Ltd | $3.379.541 | 1.270.504 | 0,36% | Aktien |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $3.037.431 | 534.759 | 0,32% | Aktien |
| ACT CAPITAL MANAGEMENT, LLC | $2.953.600 | 520.000 | 0,31% | Aktien |
| Swiss National Bank | $2.765.024 | 486.800 | 0,29% | Aktien |
| Trexquant Investment LP | $2.755.129 | 485.058 | 0,29% | Aktien |
| STATE OF WISCONSIN INVESTMENT BOARD | $2.484.557 | 437.422 | 0,26% | Aktien |
| Corient Private Wealth LP | $2.470.080 | 434.873 | 0,26% | Aktien |
| Castle Hook Partners LP | $2.328.720 | 409.986 | 0,25% | Aktien |
| Man Group plc | $2.327.107 | 409.702 | 0,25% | Aktien |
| XTX Topco Ltd | $2.277.038 | 400.887 | 0,24% | Aktien |
| JPMORGAN CHASE & CO | $2.198.464 | 391.883 | 0,23% | Aktien |
| TEMA ETFS LLC | $2.184.878 | 243.848 | 0,23% | Aktien |
| MILLENNIUM MANAGEMENT LLC | $2.117.833 | 372.858 | 0,22% | Aktien |
| Ishara Investments LP | $2.095.920 | 369.000 | 0,22% | Aktien |
| ALPS ADVISORS INC | $1.999.332 | 351.995 | 0,21% | Aktien |
| Palo Alto Investors LP | $1.855.139 | 326.609 | 0,20% | Aktien |
| MORGAN STANLEY | $1.821.349 | 320.660 | 0,19% | Aktien |
| RHUMBLINE ADVISERS | $1.798.082 | 316.566 | 0,19% | Aktien |
| D. E. Shaw & Co., Inc. | $1.774.199 | 312.359 | 0,19% | Aktien |
| Intellectus Partners, LLC | $1.666.609 | 293.417 | 0,18% | Aktien |
| Qube Research & Technologies Ltd | $1.631.415 | 287.221 | 0,17% | Aktien |
| Quantinno Capital Management LP | $1.360.479 | 239.521 | 0,14% | Aktien |
| Virtus Investment Advisers, LLC | $1.342.513 | 236.358 | 0,14% | Aktien |
| IEQ CAPITAL, LLC | $1.335.851 | 235.185 | 0,14% | Aktien |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $1.303.233 | 303.784 | 0,14% | Aktien |
| WELLINGTON MANAGEMENT GROUP LLP | $1.290.996 | 227.288 | 0,14% | Aktien |
| VANGUARD GROUP INC | $1.286.477 | 143.580 | 0,14% | Aktien |
| BARCLAYS PLC | $1.281.595 | 225.633 | 0,14% | Aktien |
| Balyasny Asset Management L.P. | $1.233.264 | 217.124 | 0,13% | Aktien |
| Bank of New York Mellon Corp | $1.223.228 | 215.357 | 0,13% | Aktien |
| ALLIANCEBERNSTEIN L.P. | $1.154.881 | 269.203 | 0,12% | Aktien |
| CITIGROUP INC | $1.131.905 | 199.279 | 0,12% | Aktien |
| GROUP ONE TRADING LLC | $1.121.630 | 197.470 | 0,12% | Aktien |
| VANGUARD ASSET MANAGEMENT, Ltd | $1.041.928 | 183.438 | 0,11% | Aktien |
| Gotham Asset Management, LLC | $1.034.623 | 182.152 | 0,11% | Aktien |
| QVT Financial LP | $970.110 | 170.794 | 0,10% | Aktien |
| Odyssean, LLC | $954.291 | 168.009 | 0,10% | Aktien |
| Shay Capital LLC | $937.200 | 165.000 | 0,10% | Aktien |
| Squarepoint Ops LLC | $932.718 | 164.211 | 0,10% | Aktien |
| SEI INVESTMENTS CO | $866.927 | 152.628 | 0,09% | Aktien |
| MetLife Investment Management, LLC | $841.185 | 148.096 | 0,09% | Aktien |
| KORNITZER CAPITAL MANAGEMENT INC /KS | $812.530 | 143.051 | 0,09% | Aktien |
| WEXFORD CAPITAL LP | $771.850 | 135.889 | 0,08% | Aktien |
| HSBC HOLDINGS PLC | $761.804 | 131.800 | 0,08% | Aktien |
| Aquatic Capital Management LLC | $759.865 | 133.779 | 0,08% | Aktien |
| Vanguard Global Advisers, LLC | $758.973 | 133.622 | 0,08% | Aktien |
| Meridian Wealth Management, LLC | $751.214 | 132.256 | 0,08% | Aktien |
| Cresset Asset Management, LLC | $687.509 | 121.040 | 0,07% | Aktien |
| LAZARD ASSET MANAGEMENT LLC | $672.932 | 118.474 | 0,07% | Aktien |
| Quadrature Capital Ltd | $659.522 | 116.113 | 0,07% | Aktien |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $659.249 | 116.065 | 0,07% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $653.768 | 115.100 | 0,07% | Verkaufsoption |
| PRELUDE CAPITAL MANAGEMENT, LLC | $622.341 | 109.567 | 0,07% | Aktien |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $598.184 | 105.314 | 0,06% | Aktien |
| Palumbo Wealth Management LLC | $584.785 | 102.955 | 0,06% | Aktien |
| Invesco Ltd. | $577.531 | 101.678 | 0,06% | Aktien |
| WELLS FARGO & COMPANY/MN | $567.693 | 99.946 | 0,06% | Aktien |
| CITADEL ADVISORS LLC | $566.864 | 99.800 | 0,06% | Verkaufsoption |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $503.816 | 88.700 | 0,05% | Kaufoption |
| JANE STREET GROUP, LLC | $482.800 | 85.000 | 0,05% | Verkaufsoption |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | $475.322 | 81.811 | 0,05% | Aktien |
| MARSHALL WACE, LLP | $473.723 | 83.402 | 0,05% | Aktien |
| JANUS HENDERSON GROUP PLC | $463.410 | 108.400 | 0,05% | Aktien |
| CWM, LLC | $456.645 | 106.444 | 0,05% | Aktien |
| State of New Jersey Common Pension Fund D | $445.590 | 78.449 | 0,05% | Aktien |
Unternehmensinsider 25 Insider · 12 Führungskräfte · 11 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Junyuan Jerry Wang | CEO, ANHEART THERAPEUTICS LTD. | 11. November 2024 S | 3.866.228 | 0 | 0 | $0 |
| Philippe Sauvage | Chief Financial Officer | 15. Juli 2026 M | 54.131 | 0 | 1 | $-286.485 |
| Jennifer A. Fox | Chief Financial Officer | 28. Februar 2023 A | — | 0 | 0 | $0 |
| Gary Hattersley | CHIEF SCIENTIFIC OFFICER | 19. August 2026 M | 0 | 0 | 1 | $-709.000 |
| Stacy Markel | CHIEF PEOPLE OFFICER | 23. Juni 2026 M | 32.591 | 0 | 1 | $-753.750 |
| Kerry Wentworth | CHIEF REGULATORY OFFICER | 23. Juni 2026 M | 53.000 | 0 | 3 | $-1.467.378 |
| Colleen Sjogren | Chief Commercial Officer | 16. Juni 2025 P | 81.000 | 0 | 0 | $0 |
| Dongfang Liu | CHIEF MEDICAL OFFICER | 2. Mai 2025 M | 12.000 | 0 | 0 | $0 |
| Moses Makunje | Title: VP, Finance and principal financial and accounting officer. | 28. Februar 2025 A | — | 0 | 0 | $0 |
| David C. Hanley | CHIEF TECHNICAL OPERATIONS | 28. Februar 2025 A | — | 0 | 0 | $0 |
| Sergey Yurasov | Chief Medical Officer | 10. Februar 2021 A | — | 0 | 0 | $0 |
| Thomas Templeman | SVP, Pharmaceutical Ops | 10. Februar 2021 A | — | 0 | 0 | $0 |
| Robert Mashal | Direktor | 9. Juni 2026 P | 225.000 | 1 | 0 | $118.250 |
| Xiangmin Cui | Direktor | 21. Mai 2026 A | 17.062.202 | 0 | 0 | $0 |
| Kathryn E Falberg | Direktor | 21. Mai 2026 A | 250.000 | 0 | 0 | $0 |
| Robert B Bazemore | Direktor | 21. Mai 2025 A | 5.000 | 0 | 0 | $0 |
| Daniel G Welch | Direktor | 24. Mai 2024 M | 659.947 | 0 | 0 | $0 |
| Oleg Nodelman | Direktor | 29. Oktober 2021 A | — | 0 | 0 | $0 |
| Graham K Cooper | Direktor | 10. Februar 2021 M | 25.000 | 0 | 0 | $0 |
| Shalini Sharp | Direktor | 10. Februar 2021 M | 35.000 | 0 | 0 | $0 |
| Faheem Hasnain | Direktor | 10. Februar 2021 M | 55.000 | 0 | 0 | $0 |
| Daniel Bradbury | Direktor | 10. Februar 2021 M | 25.000 | 0 | 0 | $0 |
| Anthony W Vernon | — | 21. Mai 2026 A | 304.100 | 0 | 0 | $0 |
| Kim D Blickenstaff | — | 21. Mai 2026 A | 172.189 | 0 | 0 | $0 |
| David Hung | — | 27. Februar 2026 A | 59.281.054 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
Aktivisten & 5%+-Eigentümer 3 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| Omega Fund V, L.P., Omega Fund V GP, L.P., Omega Fund V GP Manager, Ltd., Claudio Nessi, Otello Stampacchia ×3 Einreichungen | 18. Oktober 2024 | — | Erste Einreichung | — | SEC |
| Decheng Capital China Life Sciences USD Fund III, L.P., Decheng Capital Management III (Cayman), LLC, Decheng Capital Global Healthcare Fund (Master), LP, Decheng Capital Global Healthcare GP, LLC, Decheng Anbio Limited, Xiangmin Cui | 10. September 2024 | — | Erste Einreichung | Vorstandskampagne | SEC |
| David Hung, M.D. ×2 Einreichungen | 26. März 2024 | — | Erste Einreichung | M&A / Verkauf | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF-Besitz Gehalten von 49 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| IDNA · iShares Trust | 1,58% | 568.089 SH | 21. August 2026 | Täglich |
| PILL · Direxion Shares ETF Trust | 1,30% | 37.591 NS | 30. April 2026 | N-PORT |
| CANC · Tema ETF Trust | 1,07% | 395.313 NS | 31. Mai 2026 | N-PORT |
| PTH · Invesco Exchange-Traded Fund Trust | 1,07% | 423.144 SH | 21. August 2026 | Täglich |
| SBIO · ALPS ETF Trust | 1,06% | 357.260 NS | 31. Mai 2026 | N-PORT |
| BBP · ETFis Series Trust I | 0,84% | 112.261 NS | 30. April 2026 | N-PORT |
| IWC · iShares Trust | 0,39% | 867.790 SH | 21. August 2026 | Täglich |
| IHE · iShares Trust | 0,36% | 898.081 SH | 21. August 2026 | Täglich |
| FYC · First Trust Exchange-Traded AlphaDE… | 0,34% | 801.199 NS | 30. April 2026 | N-PORT |
| ESSC · Strategy Shares | 0,13% | 7.653 NS | 30. April 2026 | N-PORT |
| IBB · iShares Trust | 0,12% | 1.851.279 SH | 21. August 2026 | Täglich |
| FYX · First Trust Exchange-Traded AlphaDE… | 0,12% | 322.790 NS | 30. April 2026 | N-PORT |
| IWO · iShares Trust | 0,11% | 2.326.568 SH | 21. August 2026 | Täglich |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,08% | 270.228 SH | 19. August 2026 | Täglich |
| ESML · iShares Trust | 0,07% | 314.234 SH | 21. August 2026 | Täglich |
| FAD · First Trust Exchange-Traded AlphaDE… | 0,07% | 74.705 NS | 30. April 2026 | N-PORT |
| VFMO · VANGUARD WELLINGTON FUND | 0,06% | 218.055 SH | 19. August 2026 | Täglich |
| IWM · iShares Trust | 0,05% | 6.468.994 SH | 21. August 2026 | Täglich |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,05% | 220.426 SH | 21. August 2026 | Täglich |
| ISCV · iShares Trust | 0,05% | 51.844 SH | 21. August 2026 | Täglich |
| BKSE · BNY Mellon ETF Trust | 0,04% | 7.959 NS | 30. April 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,04% | 1.450.662 SH | 19. August 2026 | Täglich |
| TECB · iShares Trust | 0,03% | 24.294 SH | 21. August 2026 | Täglich |
| RSSL · Global X Funds | 0,03% | 104.380 NS | 30. April 2026 | N-PORT |
| GSSC · Goldman Sachs ETF Trust | 0,03% | 64.408 NS | 31. Mai 2026 | N-PORT |
| RB · ProShares Trust | 0,03% | 71 NS | 31. Mai 2026 | N-PORT |
| ITWO · ProShares Trust | 0,03% | 11.352 NS | 31. Mai 2026 | N-PORT |
| ISCB · iShares Trust | 0,02% | 10.466 SH | 21. August 2026 | Täglich |
| SCHA · SCHWAB STRATEGIC TRUST | 0,02% | 1.145.077 NS | 31. Mai 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,02% | 2.787.165 SH | 19. August 2026 | Täglich |
| VHT · VANGUARD WORLD FUND | 0,02% | 730.126 SH | 19. August 2026 | Täglich |
| UWM · ProShares Trust | 0,02% | 8.878 NS | 31. Mai 2026 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0,02% | 101.610 NS | 30. April 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,01% | 437.523 NS | 30. April 2026 | N-PORT |
| WSML · iShares Trust | 0,01% | 13.340 SH | 21. August 2026 | Täglich |
| URTY · ProShares Trust | 0,01% | 8.982 NS | 31. Mai 2026 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,01% | 10.097 NS | 31. Mai 2026 | N-PORT |
| HDG · ProShares Trust | 0,01% | 225 NS | 31. Mai 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,00% | 408.600 NS | 30. April 2026 | N-PORT |
| IWV · iShares Trust | 0,00% | 69.793 SH | 21. August 2026 | Täglich |
| DXUV · Dimensional ETF Trust | 0,00% | 2.055 NS | 30. April 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 310.966 SH | 21. August 2026 | Täglich |
| SCHB · SCHWAB STRATEGIC TRUST | 0,00% | 146.585 NS | 31. Mai 2026 | N-PORT |
| TILT · FlexShares Trust | 0,00% | 5.084 NS | 30. April 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,00% | 37.633 NS | 30. April 2026 | N-PORT |
| AVSC · AMERICAN CENTURY ETF TRUST | 0,00% | 2.513 NS | 31. Mai 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 8.849.329 SH | 19. August 2026 | Täglich |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 19.595 SH | 19. August 2026 | Täglich |
| SMLF · iShares Trust | — | 87.939 SH | 21. August 2026 | Täglich |